MARKER THERAPEUTICS INC (MRKR) Stock Analyst Ratings
USA - NASDAQ:MRKR - US57055L2060 - Common Stock
1.05 USD
-0.01 (-0.94%)
ChartMill assigns a Buy % Consensus number of 84% to MRKR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.33. This target is 693.34% above the current price.
MRKR was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MRKR.
In the previous month the buy percentage consensus was at a similar level.
MRKR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-01 | WBB Securities | Reiterate | Strong Buy -> Strong Buy |
| 2025-03-05 | Canaccord Genuity | Initiate | Buy |
| 2024-10-21 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2024-04-30 | Ladenburg Thalmann | Initiate | Buy |
| 2022-02-17 | Roth Capital | Downgrade | Buy -> Neutral |
| 2021-03-25 | Piper Sandler | Initiate | Overweight |
| 2021-03-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-03-18 | Cantor Fitzgerald | Initiate | Overweight |